NYSE:GMED - Globus Medical Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$42.60 -0.56 (-1.30 %)
(As of 05/19/2019 04:00 PM ET)
Previous Close$42.60
Today's Range$42.52 - $43.76
52-Week Range$38.01 - $57.83
Volume352,298 shs
Average Volume654,669 shs
Market Capitalization$4.22 billion
P/E Ratio25.51
Dividend YieldN/A
Beta0.79

Analyst Ratings

Globus Medical (NYSE:GMED) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for Globus Medical in the last 12 months. Their average twelve-month price target is $56.8889, suggesting that the stock has a possible upside of 33.54%. The high price target for GMED is $65.00 and the low price target for GMED is $49.00. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.562.562.452.45
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $56.8889$58.3333$55.9091$55.8182
Price Target Upside: 33.54% upside22.06% upside28.56% upside8.98% upside

Globus Medical (NYSE:GMED) Consensus Price Target History

Price Target History for Globus Medical (NYSE:GMED)

Globus Medical (NYSE:GMED) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/3/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$57.00 ➝ $52.00HighView Rating Details
3/19/2019OppenheimerReiterated RatingHoldLowView Rating Details
3/1/2019Cantor FitzgeraldReiterated RatingBuy$60.00LowView Rating Details
2/28/2019UBS GroupUpgradeNeutral ➝ Buy$55.00HighView Rating Details
1/2/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$64.00 ➝ $49.00HighView Rating Details
12/17/2018Credit Suisse GroupInitiated CoverageOutperform$53.00MediumView Rating Details
11/9/2018Leerink SwannBoost Price TargetOutperform$61.00 ➝ $65.00LowView Rating Details
11/9/2018Piper Jaffray CompaniesBoost Price TargetOverweight$62.00LowView Rating Details
6/27/2018Bank of AmericaDowngradeNeutral ➝ Underperform$55.00HighView Rating Details
4/16/2018BTIG ResearchReiterated RatingBuy ➝ Neutral$37.00LowView Rating Details
3/12/2018Canaccord GenuityReiterated RatingBuy$53.00LowView Rating Details
1/10/2018BarclaysReiterated RatingSell$36.00MediumView Rating Details
1/10/2018Wells Fargo & CoReiterated RatingOutperform$46.00 ➝ $51.00HighView Rating Details
11/14/2017GabelliReiterated RatingBuyN/AView Rating Details
(Data available from 5/19/2017 forward)
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Featured Article: Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel